Continuous renal replacement therapy in COVID-19—associated AKI: adding heparin to citrate to extend filter life—a retrospective cohort study

BACKGROUND: Coronavirus disease 2019 (COVID-19) may predispose patients to thrombotic events. The best anticoagulation strategy for continuous renal replacement therapy (CRRT) in such patients is still under debate. The purpose of this study was to evaluate the impact that different anticoagulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Valle, Eduardo de Oliveira, Cabrera, Carla Paulina Sandoval, Albuquerque, Claudia Coimbra César de, Silva, Giovanio Vieira da, Oliveira, Márcia Fernanda Arantes de, Sales, Gabriel Teixeira Montezuma, Smolentzov, Igor, Reichert, Bernardo Vergara, Andrade, Lucia, Seabra, Victor Faria, Lins, Paulo Ricardo Gessolo, Rodrigues, Camila Eleuterio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375288/
https://www.ncbi.nlm.nih.gov/pubmed/34412667
http://dx.doi.org/10.1186/s13054-021-03729-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375288/
https://www.ncbi.nlm.nih.gov/pubmed/34412667
http://dx.doi.org/10.1186/s13054-021-03729-9

Ejemplares similares